Literature DB >> 29558201

Inhibition of hypoxia-associated response and kynurenine production in response to hyperbaric oxygen as mechanisms involved in protection against experimental cerebral malaria.

Marcele F Bastos1, Ana Carolina A V Kayano1, João Luiz Silva-Filho1, João Conrado K Dos-Santos1, Carla Judice1, Yara C Blanco1, Nathaniel Shryock2, Michelle K Sercundes3, Luana S Ortolan3, Carolina Francelin4, Juliana A Leite1, Rafaella Oliveira5, Rosa M Elias6, Niels O S Câmara6, Stefanie C P Lopes1,5, Letusa Albrecht1,7, Alessandro S Farias1, Cristina P Vicente3, Claudio C Werneck8, Selma Giorgio9, Liana Verinaud4, Sabrina Epiphanio3, Claudio R F Marinho10, Pritesh Lalwani5, Rogerio Amino11, Julio Aliberti2,12, Fabio T M Costa1.   

Abstract

Cerebral malaria (CM) is a multifactorial syndrome involving an exacerbated proinflammatory status, endothelial cell activation, coagulopathy, hypoxia, and accumulation of leukocytes and parasites in the brain microvasculature. Despite significant improvements in malaria control, 15% of mortality is still observed in CM cases, and 25% of survivors develop neurologic sequelae for life-even after appropriate antimalarial therapy. A treatment that ameliorates CM clinical signs, resulting in complete healing, is urgently needed. Previously, we showed a hyperbaric oxygen (HBO)-protective effect against experimental CM. Here, we provide molecular evidence that HBO targets brain endothelial cells by decreasing their activation and inhibits parasite and leukocyte accumulation, thus improving cerebral microcirculatory blood flow. HBO treatment increased the expression of aryl hydrocarbon receptor over hypoxia-inducible factor 1-α (HIF-1α), an oxygen-sensitive cytosolic receptor, along with decreased indoleamine 2,3-dioxygenase 1 expression and kynurenine levels. Moreover, ablation of HIF-1α expression in endothelial cells in mice conferred protection against CM and improved survival. We propose that HBO should be pursued as an adjunctive therapy in CM patients to prolong survival and diminish deleterious proinflammatory reaction. Furthermore, our data support the use of HBO in therapeutic strategies to improve outcomes of non-CM disorders affecting the brain.-Bastos, M. F., Kayano, A. C. A. V., Silva-Filho, J. L., Dos-Santos, J. C. K., Judice, C., Blanco, Y. C., Shryock, N., Sercundes, M. K., Ortolan, L. S., Francelin, C., Leite, J. A., Oliveira, R., Elias, R. M., Câmara, N. O. S., Lopes, S. C. P., Albrecht, L., Farias, A. S., Vicente, C. P., Werneck, C. C., Giorgio, S., Verinaud, L., Epiphanio, S., Marinho, C. R. F., Lalwani, P., Amino, R., Aliberti, J., Costa, F. T. M. Inhibition of hypoxia-associated response and kynurenine production in response to hyperbaric oxygen as mechanisms involved in protection against experimental cerebral malaria.

Entities:  

Keywords:  aryl-hydrocarbon receptor; brain; endothelial cell activation; tryptophan metabolism

Mesh:

Substances:

Year:  2018        PMID: 29558201      PMCID: PMC6044055          DOI: 10.1096/fj.201700844R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  52 in total

1.  Induction of HIF-1alpha in response to hypoxia is instantaneous.

Authors:  U R Jewell; I Kvietikova; A Scheid; C Bauer; R H Wenger; M Gassmann
Journal:  FASEB J       Date:  2001-05       Impact factor: 5.191

Review 2.  The kynurenine pathway and parasitic infections that affect CNS function.

Authors:  Nicholas H Hunt; Lay Khoon Too; Loke Tim Khaw; Jintao Guo; Leia Hee; Andrew J Mitchell; Georges E Grau; Helen J Ball
Journal:  Neuropharmacology       Date:  2016-02-26       Impact factor: 5.250

Review 3.  Kynurenine pathway metabolism and immune activation: Peripheral measurements in psychiatric and co-morbid conditions.

Authors:  Barbara Strasser; Kathrin Becker; Dietmar Fuchs; Johanna M Gostner
Journal:  Neuropharmacology       Date:  2016-02-26       Impact factor: 5.250

4.  Inverse Correlation between IL-10 and HIF-1α in Macrophages Infected with Histoplasma capsulatum.

Authors:  Roger A Fecher; Michael C Horwath; Dirk Friedrich; Jan Rupp; George S Deepe
Journal:  J Immunol       Date:  2016-06-06       Impact factor: 5.422

Review 5.  Pathogenic CD8+ T cells in experimental cerebral malaria.

Authors:  Shanshan Wu Howland; Carla Claser; Chek Meng Poh; Sin Yee Gun; Laurent Rénia
Journal:  Semin Immunopathol       Date:  2015-03-13       Impact factor: 9.623

6.  Inflammatory changes in the central nervous system are associated with behavioral impairment in Plasmodium berghei (strain ANKA)-infected mice.

Authors:  Norinne Lacerda-Queiroz; David Henrique Rodrigues; Márcia Carvalho Vilela; Aline Silva de Miranda; Débora Cristina Guerra Amaral; Elizabeth Ribeiro da Silva Camargos; Leonardo José de Moura Carvalho; Charles L Howe; Mauro Martins Teixeira; Antônio Lúcio Teixeira
Journal:  Exp Parasitol       Date:  2010-02-06       Impact factor: 2.011

7.  Role of the aryl hydrocarbon receptor in the immune response profile and development of pathology during Plasmodium berghei Anka infection.

Authors:  Fatima Brant; Aline S Miranda; Lisia Esper; David Henrique Rodrigues; Lucas Miranda Kangussu; Daniella Bonaventura; Frederico Marianetti Soriani; Vanessa Pinho; Danielle G Souza; Milene Alvarenga Rachid; Louis M Weiss; Herbert B Tanowitz; Mauro Martins Teixeira; Antônio Lucio Teixeira; Fabiana Simão Machado
Journal:  Infect Immun       Date:  2014-05-12       Impact factor: 3.441

Review 8.  Hyperbaric oxygen in the treatment of patients with cerebral stroke, brain trauma, and neurologic disease.

Authors:  Noori S Al-Waili; Glenn J Butler; Jorge Beale; Mahdi S Abdullah; R W Bill Hamilton; Boke Y Lee; Paul Lucus; Michael W W Allen; Richard L Petrillo; Zev Carrey; Michael Finkelstein
Journal:  Adv Ther       Date:  2005 Nov-Dec       Impact factor: 3.845

9.  Specific receptor usage in Plasmodium falciparum cytoadherence is associated with disease outcome.

Authors:  Lucy B Ochola; Bethsheba R Siddondo; Harold Ocholla; Siana Nkya; Eva N Kimani; Thomas N Williams; Johnstone O Makale; Anne Liljander; Britta C Urban; Pete C Bull; Tadge Szestak; Kevin Marsh; Alister G Craig
Journal:  PLoS One       Date:  2011-03-03       Impact factor: 3.240

10.  Activated Brain Endothelial Cells Cross-Present Malaria Antigen.

Authors:  Shanshan W Howland; Chek Meng Poh; Laurent Rénia
Journal:  PLoS Pathog       Date:  2015-06-05       Impact factor: 6.823

View more
  2 in total

Review 1.  Recent advances in the neuroprotective effects of medical gases.

Authors:  Yue-Zhen Wang; Ting-Ting Li; Hong-Ling Cao; Wan-Chao Yang
Journal:  Med Gas Res       Date:  2019 Apr-Jun

Review 2.  Survey of Molecular Mechanisms of Hyperbaric Oxygen in Tissue Repair.

Authors:  Joerg Lindenmann; Christian Smolle; Lars-Peter Kamolz; Freyja Maria Smolle-Juettner; Wolfgang F Graier
Journal:  Int J Mol Sci       Date:  2021-10-29       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.